142 related articles for article (PubMed ID: 12822183)
1. Synthesis of 2-methylsulfanyl-1H-imidazoles as novel non-nucleoside reverse transcriptase inhibitors (NNRTIs).
Loksha YM; El-Badawi MA; El-Barbary AA; Pedersen EB; Nielsen C
Arch Pharm (Weinheim); 2003 Jun; 336(3):175-80. PubMed ID: 12822183
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of 2-(aminocarbonylmethylthio)-1H-imidazoles as novel Capravirine analogues.
Loksha YM; el-Barbary AA; el-Badawi MA; Nielsen C; Pedersen EB
Bioorg Med Chem; 2005 Jul; 13(13):4209-20. PubMed ID: 15896963
[TBL] [Abstract][Full Text] [Related]
3. Dihydro(alkylthio)(naphthylmethyl)oxopyrimidines: novel non-nucleoside reverse transcriptase inhibitors of the S-DABO series.
Mai A; Artico M; Sbardella G; Quartarone S; Massa S; Loi AG; De Montis A; Scintu F; Putzolu M; La Colla P
J Med Chem; 1997 May; 40(10):1447-54. PubMed ID: 9154967
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, biological evaluation and molecular modeling studies of N-aryl-2-arylthioacetamides as non-nucleoside HIV-1 reverse transcriptase inhibitors.
Xiaohe Z; Yu Q; Hong Y; Xiuqing S; Rugang Z
Chem Biol Drug Des; 2010 Oct; 76(4):330-9. PubMed ID: 20731670
[TBL] [Abstract][Full Text] [Related]
5. Non-nucleoside HIV reverse transcriptase inhibitors, Part 6[1]: synthesis and anti-HIV activity of novel 2-[(arylcarbonylmethyl)thio]-6-arylthio DABO analogues.
Sun GF; Kuang YY; Chen FE; De Clercq E; Balzarini J; Pannecouque C
Arch Pharm (Weinheim); 2005 Oct; 338(10):457-61. PubMed ID: 16211654
[TBL] [Abstract][Full Text] [Related]
6. Novel 1-[2-(diarylmethoxy)ethyl]-2-methyl-5-nitroimidazoles as HIV-1 non-nucleoside reverse transcriptase inhibitors. A structure-activity relationship investigation.
De Martino G; La Regina G; Di Pasquali A; Ragno R; Bergamini A; Ciaprini C; Sinistro A; Maga G; Crespan E; Artico M; Silvestri R
J Med Chem; 2005 Jun; 48(13):4378-88. PubMed ID: 15974590
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of novel uracil non-nucleoside derivatives as potential reverse transcriptase inhibitors of HIV-1.
El-Brollosy NR; Al-Deeb OA; El-Emam AA; Pedersen EB; La Colla P; Collu G; Sanna G; Loddo R
Arch Pharm (Weinheim); 2009 Nov; 342(11):663-70. PubMed ID: 19856332
[TBL] [Abstract][Full Text] [Related]
8. The design and synthesis of 9-phenylcyclohepta[d]pyrimidine-2,4-dione derivatives as potent non-nucleoside inhibitors of HIV reverse transcriptase.
Wang X; Lou Q; Guo Y; Xu Y; Zhang Z; Liu J
Org Biomol Chem; 2006 Sep; 4(17):3252-8. PubMed ID: 17036113
[TBL] [Abstract][Full Text] [Related]
9. Studies of non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 2: synthesis and structure-activity relationships of 2-cyano and 2-hydroxy thiazolidenebenzenesulfonamide derivatives.
Masuda N; Yamamoto O; Fujii M; Ohgami T; Fujiyasu J; Kontani T; Moritomo A; Orita M; Kurihara H; Koga H; Kageyama S; Ohta M; Inoue H; Hatta T; Shintani M; Suzuki H; Sudo K; Shimizu Y; Kodama E; Matsuoka M; Fujiwara M; Yokota T; Shigeta S; Baba M
Bioorg Med Chem; 2005 Feb; 13(4):949-61. PubMed ID: 15670903
[TBL] [Abstract][Full Text] [Related]
10. Parallel one-pot synthesis and structure-activity relationship study of symmetric formimidoester disulfides as a novel class of potent non-nucleoside HIV-1 reverse transcriptase inhibitors.
Cesarini S; Spallarossa A; Ranise A; Schenone S; Bruno O; La Colla P; Casula L; Collu G; Sanna G; Loddo R
Bioorg Med Chem; 2008 Jun; 16(12):6353-63. PubMed ID: 18502646
[TBL] [Abstract][Full Text] [Related]
11. Non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 11: structural modulations of diaryltriazines with potent anti-HIV activity.
Xiong YZ; Chen FE; Balzarini J; De Clercq E; Pannecouque C
Eur J Med Chem; 2008 Jun; 43(6):1230-6. PubMed ID: 17869386
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and in vitro anti-HIV evaluation of a new series of 6-arylmethyl-substituted S-DABOs as potential non-nucleoside HIV-1 reverse transcriptase inhibitors.
Wang YP; Chen FE; De Clercq E; Balzarini J; Pannecouque C
Eur J Med Chem; 2009 Mar; 44(3):1016-23. PubMed ID: 18692274
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, antibacterial and potential anti-HIV activity of some novel imidazole analogs.
Ganguly S; Vithlani VV; Kesharwani AK; Kuhu R; Baskar L; Mitramazumder P; Sharon A; Dev A
Acta Pharm; 2011 Jun; 61(2):187-201. PubMed ID: 21684846
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, biological activity and docking study of imidazol-5-one as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.
Mokale SN; Lokwani D; Shinde DB
Bioorg Med Chem; 2012 May; 20(9):3119-27. PubMed ID: 22480850
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and studies of new 2-(coumarin-4-yloxy)-4,6-(substituted)-S-triazine derivatives as potential anti-HIV agents.
Mahajan DH; Pannecouque C; De Clercq E; Chikhalia KH
Arch Pharm (Weinheim); 2009 May; 342(5):281-90. PubMed ID: 19415671
[TBL] [Abstract][Full Text] [Related]
16. Arylthiopyrrole (AThP) derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors: synthesis, structure-activity relationships, and docking studies (part 2).
Lavecchia A; Costi R; Artico M; Miele G; Novellino E; Bergamini A; Crespan E; Maga G; Di Santo R
ChemMedChem; 2006 Dec; 1(12):1379-90. PubMed ID: 17089434
[TBL] [Abstract][Full Text] [Related]
17. Imidazo[1,2-a]pyridin-3-amines as potential HIV-1 non-nucleoside reverse transcriptase inhibitors.
Bode ML; Gravestock D; Moleele SS; van der Westhuyzen CW; Pelly SC; Steenkamp PA; Hoppe HC; Khan T; Nkabinde LA
Bioorg Med Chem; 2011 Jul; 19(14):4227-37. PubMed ID: 21700466
[TBL] [Abstract][Full Text] [Related]
18. Computer-aided design, synthesis, and anti-HIV-1 activity in vitro of 2-alkylamino-6-[1-(2,6-difluorophenyl)alkyl]-3,4-dihydro-5-alkylpyrimidin-4(3H)-ones as novel potent non-nucleoside reverse transcriptase inhibitors, also active against the Y181C variant.
Ragno R; Mai A; Sbardella G; Artico M; Massa S; Musiu C; Mura M; Marturana F; Cadeddu A; La Colla P
J Med Chem; 2004 Feb; 47(4):928-34. PubMed ID: 14761194
[TBL] [Abstract][Full Text] [Related]
19. Nitroimidazoles. V. Synthesis and anti-HIV evaluation of new 5-substituted piperazinyl-4-nitroimidazole derivatives.
Al-Soud YA; Al-Masoudi NA; Hassan HG; De Clercq E; Pannecouque C
Acta Pharm; 2007 Dec; 57(4):379-93. PubMed ID: 18165184
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and SAR of a novel pyrazinone series with non-nucleoside HIV-1 reverse transcriptase inhibitory activity.
Heeres J; de Jonge MR; Koymans LM; Daeyaert FF; Vinkers M; Van Aken KJ; Arnold E; Das K; Kilonda A; Hoornaert GJ; Compernolle F; Cegla M; Azzam RA; Andries K; de Béthune MP; Azijn H; Pauwels R; Lewi PJ; Janssen PA
J Med Chem; 2005 Mar; 48(6):1910-8. PubMed ID: 15771435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
